These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8002525)
1. Interaction of transferrin saturated with iron with lung surfactant in respiratory failure. Hallman M; Sarnesto A; Bry K J Appl Physiol (1985); 1994 Aug; 77(2):757-66. PubMed ID: 8002525 [TBL] [Abstract][Full Text] [Related]
2. Transferrin modifies surfactant responsiveness in acute respiratory failure: role of iron-free transferrin as an antioxidant. Hallman M; Chundu V; Barsotti M; Bry K Pediatr Pulmonol; 1996 Jul; 22(1):14-22. PubMed ID: 8856799 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of exogenous transferrin against hyperoxia: a study on premature rabbits. Shah M; Bry K; Hallman M Pediatr Pulmonol; 1997 Dec; 24(6):429-37. PubMed ID: 9448235 [TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Issa A; Lappalainen U; Kleinman M; Bry K; Hallman M Pediatr Res; 1999 Feb; 45(2):247-54. PubMed ID: 10022598 [TBL] [Abstract][Full Text] [Related]
5. Respiratory failure following anti-lung serum: study on mechanisms associated with surfactant system damage. Lachmann B; Hallman M; Bergmann KC Exp Lung Res; 1987; 12(2):163-80. PubMed ID: 3569167 [TBL] [Abstract][Full Text] [Related]
6. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Strayer DS; Herting E; Sun B; Robertson B Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554 [TBL] [Abstract][Full Text] [Related]
7. Lung protein leakage in respiratory failure induced by a hybridoma making monoclonal antibody to the hydrophobic surfactant-associated polypeptide SP-B. Suzuki Y; Robertson B; Fujita Y; Grossmann G; Kogishi K; Curstedt T Int J Exp Pathol; 1992 Jun; 73(3):325-33. PubMed ID: 1622844 [TBL] [Abstract][Full Text] [Related]
8. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123 [TBL] [Abstract][Full Text] [Related]
9. Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids. Hattori A; Kuroki Y; Katoh T; Takahashi H; Shen HQ; Suzuki Y; Akino T Am J Respir Cell Mol Biol; 1996 Jun; 14(6):608-19. PubMed ID: 8652189 [TBL] [Abstract][Full Text] [Related]
10. Respiratory distress and surfactant inhibition following vagotomy in rabbits. Berry D; Ikegami M; Jobe A J Appl Physiol (1985); 1986 Nov; 61(5):1741-8. PubMed ID: 3781984 [TBL] [Abstract][Full Text] [Related]
11. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Haddad IY; Ischiropoulos H; Holm BA; Beckman JS; Baker JR; Matalon S Am J Physiol; 1993 Dec; 265(6 Pt 1):L555-64. PubMed ID: 8279572 [TBL] [Abstract][Full Text] [Related]
13. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755 [TBL] [Abstract][Full Text] [Related]
14. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury. Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Ennema JJ; Kobayashi T; Robertson B; Curstedt T Acta Anaesthesiol Scand; 1988 Nov; 32(8):665-71. PubMed ID: 3213391 [TBL] [Abstract][Full Text] [Related]
16. Effects of simultaneous exposure of surfactant to serum proteins and free radicals. Marzan Y; Mora R; Butler A; Butler M; Ingenito EP Exp Lung Res; 2002 Mar; 28(2):99-121. PubMed ID: 11868826 [TBL] [Abstract][Full Text] [Related]
17. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Hallman M; Merritt TA; Akino T; Bry K Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552 [TBL] [Abstract][Full Text] [Related]
18. Lung surfactant phospholipids in the foetus, newborn, and in the adult; evidence of abnormality in respiratory failure. Hallman M Ann Chir Gynaecol Suppl; 1982; 196():19-23. PubMed ID: 6961877 [TBL] [Abstract][Full Text] [Related]
19. Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. Lotze A; Whitsett JA; Kammerman LA; Ritter M; Taylor GA; Short BL J Pediatr; 1990 Mar; 116(3):435-40. PubMed ID: 2308037 [TBL] [Abstract][Full Text] [Related]
20. Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation. Wright JR; Borron P; Brinker KG; Folz RJ Am J Respir Cell Mol Biol; 2001 May; 24(5):513-7. PubMed ID: 11350819 [No Abstract] [Full Text] [Related] [Next] [New Search]